TP73 and astrocytoma (excluding glioblastoma): In glioma, high expression of TP73-AS1 is significantly correlated with poor patient outcome in all tested cases, namely, IDH wt and mutant tumors, astrocytoma, and oligodendroglioma (Fig. 1e).